LymphedemaV1, Main, Exploration, bibRecord, 001A52

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

Identifieur interne : 001A52 ( Main/Exploration ); précédent : 001A51; suivant : 001A53

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

Auteurs : M. Sladden [Australie] ; S. Zagarella ; C. Popescu ; M. Bigby

Source :

The British journal of dermatology [ 1365-2133 ] ; 2015.

RBID : pubmed:25776246

Descripteurs français

KwdFr :
- Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Mâle, Mélanome (anatomopathologie), Tumeurs cutanées (anatomopathologie).
MESH :
- anatomopathologie : Mélanome, Tumeurs cutanées.
- Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Mâle.

English descriptors

KwdEn :
- Female, Humans, Lymph Node Excision, Male, Melanoma (pathology), Sentinel Lymph Node Biopsy, Skin Neoplasms (pathology).
MESH :
- pathology : Melanoma, Skin Neoplasms.
- Female, Humans, Lymph Node Excision, Male, Sentinel Lymph Node Biopsy.

Abstract

Sentinel lymph node biopsy (SLNB) was developed in the hope that it would improve outcomes for patients with melanoma. SLNB is an area of discussion and controversy in melanoma medicine. The final trial results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) have now been published and the authors suggest their long-term results 'clearly validate the use of sentinel-node biopsy in patients with intermediate-thickness or thick primary melanomas'. An accompanying editorial states that MSLT-I is a practice-changing trial.

DOI: 10.1111/bjd.13675
PubMed: 25776246

Affiliations:

Australie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.</title>
<author><name sortKey="Sladden, M" sort="Sladden, M" uniqKey="Sladden M" first="M" last="Sladden">M. Sladden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249, Australia. m.sladden@doctors.org.uk.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249</wicri:regionArea>
<wicri:noRegion>7249</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zagarella, S" sort="Zagarella, S" uniqKey="Zagarella S" first="S" last="Zagarella">S. Zagarella</name>
</author>
<author><name sortKey="Popescu, C" sort="Popescu, C" uniqKey="Popescu C" first="C" last="Popescu">C. Popescu</name>
</author>
<author><name sortKey="Bigby, M" sort="Bigby, M" uniqKey="Bigby M" first="M" last="Bigby">M. Bigby</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25776246</idno>
<idno type="pmid">25776246</idno>
<idno type="doi">10.1111/bjd.13675</idno>
<idno type="wicri:Area/PubMed/Corpus">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F84</idno>
<idno type="wicri:Area/PubMed/Curation">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F84</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F84</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F84</idno>
<idno type="wicri:Area/Ncbi/Merge">007144</idno>
<idno type="wicri:Area/Ncbi/Curation">007144</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007144</idno>
<idno type="wicri:Area/Main/Merge">001A55</idno>
<idno type="wicri:Area/Main/Curation">001A52</idno>
<idno type="wicri:Area/Main/Exploration">001A52</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.</title>
<author><name sortKey="Sladden, M" sort="Sladden, M" uniqKey="Sladden M" first="M" last="Sladden">M. Sladden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249, Australia. m.sladden@doctors.org.uk.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Tasmania, 36 Thistle St West, South Launceston, Tasmania, 7249</wicri:regionArea>
<wicri:noRegion>7249</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zagarella, S" sort="Zagarella, S" uniqKey="Zagarella S" first="S" last="Zagarella">S. Zagarella</name>
</author>
<author><name sortKey="Popescu, C" sort="Popescu, C" uniqKey="Popescu C" first="C" last="Popescu">C. Popescu</name>
</author>
<author><name sortKey="Bigby, M" sort="Bigby, M" uniqKey="Bigby M" first="M" last="Bigby">M. Bigby</name>
</author>
</analytic>
<series><title level="j">The British journal of dermatology</title>
<idno type="eISSN">1365-2133</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Male</term>
<term>Melanoma (pathology)</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Skin Neoplasms (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
<term>Mélanome (anatomopathologie)</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term>
<term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Male</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sentinel lymph node biopsy (SLNB) was developed in the hope that it would improve outcomes for patients with melanoma. SLNB is an area of discussion and controversy in melanoma medicine. The final trial results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) have now been published and the authors suggest their long-term results 'clearly validate the use of sentinel-node biopsy in patients with intermediate-thickness or thick primary melanomas'. An accompanying editorial states that MSLT-I is a practice-changing trial.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
</list>
<tree><noCountry><name sortKey="Bigby, M" sort="Bigby, M" uniqKey="Bigby M" first="M" last="Bigby">M. Bigby</name>
<name sortKey="Popescu, C" sort="Popescu, C" uniqKey="Popescu C" first="C" last="Popescu">C. Popescu</name>
<name sortKey="Zagarella, S" sort="Zagarella, S" uniqKey="Zagarella S" first="S" last="Zagarella">S. Zagarella</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Sladden, M" sort="Sladden, M" uniqKey="Sladden M" first="M" last="Sladden">M. Sladden</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A52 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A52 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25776246
   |texte=   No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25776246" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.